UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 23, 2012

 

THORATEC CORPORATION

(Exact name of registrant as specified in its charter)

 

California

 

000-49798

 

94-2340464

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

6035 Stoneridge Drive

Pleasanton, California  94588

(Address of principal executive offices including zip code)

 

(925) 847-8600

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07.              Submission of Matters to a Vote of Security Holders.

 

At the Thoratec Corporation (the “Company”) Annual Meeting of Shareholders held on May 23, 2012 (the “Annual Meeting”), the shareholders of the Company voted on the following four proposals, each of which are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 9, 2012.

 

Proposal No. 1: To elect nine directors to serve for the ensuing year or until their successors are elected and qualified:

 

 

 

Number of Votes

 

 

 

For

 

Withheld

 

Non Votes

 

Neil F. Dimick

 

47,861,217

 

9,133,191

 

4,218,903

 

Gerhard F. Burbach

 

47,769,576

 

2,390,997

 

4,218,903

 

J. Daniel Cole

 

47,536,588

 

2,623,985

 

4,218,903

 

Steven H. Collis

 

46,664,615

 

3,495,958

 

4,218,903

 

Elisha W. Finney

 

47,885,370

 

2,275,203

 

4,218,903

 

D. Keith Grossman

 

47,756,991

 

2,403,582

 

4,218,903

 

William A. Hawkins, III

 

47,759,660

 

2,400,913

 

4,218,903

 

Paul A. LaViolette

 

46,699,089

 

3,461,484

 

4,218,903

 

Daniel M. Mulvena

 

46,358,167

 

3,802,406

 

4,218,903

 

 

Proposal No. 2:  To approve the amendment and restatement of the Thoratec Corporation 2006 Incentive Stock Plan:

 

 

 

Number of Votes

 

For

 

40,931,269

 

Against

 

8,809,871

 

Abstain

 

1,178,748

 

Non Votes

 

4,218,903

 

 

Proposal No. 3: To conduct an advisory vote on the compensation of the Company’s named executive officers:

 

 

 

Number of Votes

 

For

 

46,493,671

 

Against

 

3,932,932

 

Abstain

 

493,285

 

Non Votes

 

4,218,903

 

 

Proposal No. 4:  Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent auditors for its fiscal year ending December 29, 2012:

 

 

 

Number of Votes

 

For

 

54,692,520

 

Against

 

437,059

 

Abstain

 

9,212

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated as of May 29, 2012

 

 

THORATEC CORPORATION

 

 

 

By:

 /s/ Gerhard F. Burbach

 

 

 

 

 

Gerhard F. Burbach

 

 

President and Chief Executive Officer

 

3